God  our Guide   CIDPUSA Foundation to help humanity discover natural cures for all diseases
 

CIDPUSA.ORG

 
Home
Diagnosis
Treatment
Pathology
Variants
CIDP info
Fibromyalgia
IVIG
Anti-inflammatory Diet
Burning  Feet Home
Services Page
Chronic Fatigue
Autoimmune diseases
Prognosis
Bible healing
Celiac disease

Diabetic polyneuropathy

Polyneuropathy treatment

 Polyneuropathy

ALA in diabetes

Reversing diabetes

Brown rice

Diabetic study halted

Broccoli in Diabetics

Diabetic amytrophy

Homeopathy & stress

Magentic

Circadian rhythm

Autonomic neuropathy

antidepressants

carbon dioxide

CDC VACCINE ALERT

VACCINE INJURY RULING

   Aids

   Cidp

  MS

   Alzheimers

   Burning Feet

FMS & CFS

Weakness

Variants

 

 

  Diabetes Type I
             All Natural treatments for all diseases please read this link  
Please click the +1 button if you like this page Thanks
Special GoogleHealth Search
 
Vitamin E
 

Treating Type 1 Diabetes By

 Eliminating B Cells

— Autoimmune diseases such as type 1 diabetes and rheumatoid arthritis (RA) are caused when immune cells known as lymphocytes attack our own body tissues.


Depletion of the B cell subset of lymphocytes using an antibody specific for the protein CD20 has been shown to be effective for the treatment of RA. The effectiveness of such an approach for the treatment of type I diabetes is not known, largely because the reagents to address this question in preclinical models have been lacking.

This problem has now been overcome by Li Wen and colleagues from Yale School of Medicine, New Haven, who have developed the necessary tools and shown that depletion of B cells can both prevent diabetes and reverse established disease in mice. In the accompanying commentary, Hélène Bour-Jordan and Jeffrey Bluestone from the University of California, San Francisco, highlight the importance of these advances for developing and optimizing the potential of CD20-specific antibodies for the treatment of type 1 diabetes.

In the study, autoimmune diabetes--susceptible mice were engineered such that their B cells expressed human CD20. Depletion of B cells in these mice before they showed signs of diabetes, using a single dose of a CD20-specific antibody, delayed and/or reduced the onset of disease.

Similarly, in mice already showing signs of diabetes, a single dose of the CD20-specific antibody reversed disease in a substantial proportion of the mice. Furthermore, the mechanism behind the protection afforded by CD20-specific antibody treatment was shown to be associated with increased numbers of regulatory T cells and B cells.

The article "Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in

 

 

             Healing  Mercury in makeup   Subcutaneous IVIg PAGE.